Merck & Co Inc (MRK)
131.94
+0.19
(+0.14%)
USD |
NYSE |
Mar 28, 16:00
131.99
+0.05
(+0.04%)
After-Hours: 20:00
Merck Cash from Operations (TTM): 13.01B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 13.01B |
September 30, 2023 | 17.19B |
June 30, 2023 | 15.08B |
March 31, 2023 | 15.67B |
December 31, 2022 | 19.10B |
September 30, 2022 | 19.70B |
June 30, 2022 | 18.89B |
March 31, 2022 | 17.08B |
December 31, 2021 | 14.11B |
September 30, 2021 | 13.08B |
June 30, 2021 | 10.46B |
March 31, 2021 | 11.34B |
December 31, 2020 | 10.25B |
September 30, 2020 | 11.04B |
June 30, 2020 | 13.09B |
March 31, 2020 | 12.81B |
December 31, 2019 | 13.44B |
September 30, 2019 | 12.24B |
June 30, 2019 | 10.80B |
March 31, 2019 | 11.10B |
December 31, 2018 | 10.92B |
September 30, 2018 | 11.35B |
June 30, 2018 | 7.385B |
March 31, 2018 | 7.32B |
December 31, 2017 | 6.451B |
Date | Value |
---|---|
September 30, 2017 | 6.064B |
June 30, 2017 | 10.21B |
March 31, 2017 | 8.489B |
December 31, 2016 | 10.38B |
September 30, 2016 | 10.99B |
June 30, 2016 | 11.33B |
March 31, 2016 | 12.43B |
December 31, 2015 | 12.54B |
September 30, 2015 | 7.257B |
June 30, 2015 | 8.294B |
March 31, 2015 | 7.912B |
December 31, 2014 | 7.989B |
September 30, 2014 | 12.05B |
June 30, 2014 | 11.65B |
March 31, 2014 | 11.67B |
December 31, 2013 | 11.65B |
September 30, 2013 | 10.44B |
June 30, 2013 | 9.627B |
March 31, 2013 | 10.21B |
December 31, 2012 | 10.02B |
September 30, 2012 | 11.45B |
June 30, 2012 | 12.88B |
March 31, 2012 | 12.82B |
December 31, 2011 | 12.38B |
September 30, 2011 | 12.69B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
10.25B
Minimum
Dec 2020
19.70B
Maximum
Sep 2022
13.97B
Average
13.09B
Median
Cash from Operations (TTM) Benchmarks
Amgen Inc | 8.471B |
Gilead Sciences Inc | 8.006B |
Johnson & Johnson | 22.79B |
Harpoon Therapeutics Inc (DELISTED) | -69.38M |
Moderna Inc | -3.118B |